Ticker Symbol: ABIO
ARCA biopharma Inc
$2.43 - 05-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000907654
Company Profile
arca was founded on the belief that a precision medicine approach to drug development, tailoring medical treatment to the individual genetic characteristics of patients, can enable more effective therapies, improve patient outcomes and reduce healthcare costs. arca’s lead development program is intended to be a direct implementation of those ideas. gencaro™ (bucindolol hydrochloride) is being developed as a potential treatment for atrial fibrillation (af). arca has identified genetic variations in cardiac receptors that we believe may predict individual patient response to gencaro™, giving gencaro™ the potential to be the first genetically-targeted prevention treatment for af.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2835
Address: 11080 Circle Point Rd Ste 140
Website: http://arcabio.com/
CEO: Michael Bristow
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $2.02
Change:
-
(
0.00%)
Days Range: $2.00 - $2.04
Beta: 0.06
52wk. High: $2.70
52wk. Low: $1.85
Ytd. Change -14.35%
50 Day Moving Average: $2.02
200 Day Moving Average: $2.04
Shares Outstanding: 14410143
Valuation
Market Cap: 2.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A